Valuation: Boston Scientific Corporation

Market Cap 71.45B 61.82B 57.71B 52.97B 99.57B 6,802B 101B 677B 265B 3,408B 268B 262B 11,270B P/E 2026 *
18.4x
P/E 2027 * 19.2x
Enterprise Value 80.16B 69.37B 64.75B 59.43B 112B 7,631B 113B 760B 298B 3,823B 301B 294B 12,645B EV / Sales 2026 *
3.75x
EV / Sales 2027 * 3.44x
Free-Float
82.5%
Yield 2026 *
-
Yield 2027 * -
1 day-1.50%
1 week+7.20%
Current month+5.52%
1 month+10.56%
3 months-11.95%
6 months-35.35%
Current year-48.29%
1 week 47.1
Extreme 47.1
50.16
1 month 42.2
Extreme 42.2
50.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Buy

Director

140 0.0000%
03/08/26 Buy

Chief Executive Officer

208,359 0.0141%
31/07/26 Other

Executive/Senior Manager

64,198 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.02%+7.20%-52.10%-2.78% 71.45B
+2.41%+2.99%+32.31%+8.27% 214B
+2.39%+4.38%+4.91%-19.62% 141B
+1.36%+7.32%-20.09%+22.47% 132B
+0.45%+3.22%+14.13%+12.78% 51.48B
+1.05%+6.21%-13.37%-19.84% 50.15B
+3.28%+5.23%+28.91%+15.57% 39.92B
+1.79%+6.98%+46.50%+40.35% 39.24B
-5.06%+1.62%-24.43%+18.24% 32.2B
+2.08%+2.62%+2.59%-5.44% 31.76B
Average +0.19%+3.90%+1.94%+7.00% 80.33B
Weighted average by Cap. -0.13%+3.30%+4.45%+5.06%

Financials

2026 *2027 *
Net sales 21.37B 18.49B 17.26B 15.84B 29.78B 2,034B 30.23B 202B 79.36B 1,019B 80.22B 78.48B 3,370B 22.34B 19.33B 18.04B 16.56B 31.13B 2,126B 31.61B 212B 82.97B 1,065B 83.86B 82.04B 3,524B
Net income 3.84B 3.33B 3.1B 2.85B 5.36B 366B 5.44B 36.42B 14.27B 183B 14.43B 14.12B 606B 3.74B 3.24B 3.02B 2.77B 5.21B 356B 5.29B 35.43B 13.89B 178B 14.04B 13.73B 590B
Net Debt 8.72B 7.54B 7.04B 6.46B 12.15B 830B 12.33B 82.6B 32.38B 416B 32.73B 32.02B 1,375B 5.45B 4.72B 4.4B 4.04B 7.6B 519B 7.71B 51.66B 20.25B 260B 20.47B 20.02B 860B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
07/08/26 $49.31 +0.02% 11,155,621
06/08/26 $49.30 +3.27% 21,398,972
05/08/26 $47.74 -2.75% 16,512,147
04/08/26 $49.09 +1.36% 21,565,121
03/08/26 $48.43 +3.64% 20,379,998
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
49.31USD
Average target price
62.69USD
Spread / Average Target
+27.13%

Quarterly revenue - Rate of surprise